First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component

BACKGROUND: To compare the efficacy of first‐line bevacizumab plus chemotherapy with cetuximab plus chemotherapy based on the stratification of metastatic colorectal cancer (mCRC) patients with mucinous adenocarcinoma (MA) or mucinous component (MC). METHODS: A retrospective study involving all mCRC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yu‐Wen, Long, Yi‐Xiu, Chen, Ye, Liu, Ji‐Yan, Pu, Dan, Huang, Jia‐Yan, Bi, Feng, Li, Qiu, Gou, Hong‐Feng, Qiu, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124114/
https://www.ncbi.nlm.nih.gov/pubmed/33939281
http://dx.doi.org/10.1002/cam4.3876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124114/
https://www.ncbi.nlm.nih.gov/pubmed/33939281
http://dx.doi.org/10.1002/cam4.3876

Ejemplares similares